Beckley Psytech

Beckley Psytech company information, Employees & Contact Information

Explore related pages

Beckley Psytech email format Beckley Psytech management contacts

Related company profiles:

Beckley Psytech Ltd is a private, independent biopharmaceutical company developing effective, rapid-acting and accessible medicines for people living with mental health conditions.

Company Details

Employees
66
Founded
-
Address
Oxford, Gb
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
beckleypsytech.com
Keywords
Santa Cruz.
HQ
Oxford
Competitors
Mindbloom, Solvonis Therapeutics (formerly Awakn), MindMed, Compass Pathways, atai Life Sciences, Cybin Inc, Clerkenwell Health, Lykos Therapeutics, Delix Therapeutics, Multidisciplinary Association for Psychedelic Studies (MAPS).
Looking for a particular Beckley Psytech employee's phone or email?

Beckley Psytech Questions

News

atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression - Investing News Network

atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression Investing News Network

atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression - Santé log

atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression Santé log

atai Life Sciences and Beckley Psytech Announce Strategic Merger to Create Market Leader in Psychedelic Mental Health Treatments - Nasdaq

atai Life Sciences and Beckley Psytech Announce Strategic Merger to Create Market Leader in Psychedelic Mental Health Treatments Nasdaq

atai's BPL-003 Shows 50% Remission Rate in Phase 2a Depression Trial | ATAI Stock News - Stock Titan

atai's BPL-003 Shows 50% Remission Rate in Phase 2a Depression Trial | ATAI Stock News Stock Titan

atai Life Sciences and Beckley Psytech Announce Positive Phase 2b Results for BPL-003 in Treatment-Resistant Depression - Quiver Quantitative

atai Life Sciences and Beckley Psytech Announce Positive Phase 2b Results for BPL-003 in Treatment-Resistant Depression Quiver Quantitative

Atai Life Sciences plans to merge with psychedelic startup Beckley Psytech - statnews.com

Atai Life Sciences plans to merge with psychedelic startup Beckley Psytech statnews.com

atai and Beckley Psytech’s psychedelic wins in Phase IIb depression trial - Clinical Trials Arena

atai and Beckley Psytech’s psychedelic wins in Phase IIb depression trial Clinical Trials Arena

Beckley Psytech's psychedelic reduces depression symptoms in phase 2, triggering Atai merger - Fierce Biotech

Beckley Psytech's psychedelic reduces depression symptoms in phase 2, triggering Atai merger Fierce Biotech

Beckley Psytech announces positive topline data from Part 2 - GlobeNewswire

Beckley Psytech announces positive topline data from Part 2 GlobeNewswire

atai Life Sciences Receives FDA Breakthrough for BPL-003 in TRD | ATAI Stock News - Stock Titan

atai Life Sciences Receives FDA Breakthrough for BPL-003 in TRD | ATAI Stock News Stock Titan

BPL-003 for Alcohol Use Disorder: Positive Topline Results of Phase 2A Study - Psychiatric Times

BPL-003 for Alcohol Use Disorder: Positive Topline Results of Phase 2A Study Psychiatric Times

Beckley Psytech Strengthens Pipeline and Development Team With Acquisition of Eleusis Therapeutics Limited - Psychedelic Alpha

Beckley Psytech Strengthens Pipeline and Development Team With Acquisition of Eleusis Therapeutics Limited Psychedelic Alpha

Beckley Psytech completes oversubscribed $80m (£58m) fundraise to develop portfolio of psychedelic medicine breakthroughs - Business Wire

Beckley Psytech completes oversubscribed $80m (£58m) fundraise to develop portfolio of psychedelic medicine breakthroughs Business Wire

Beckley Psytech announces positive results for ELE-101 in depression trial - PharmaTimes

Beckley Psytech announces positive results for ELE-101 in depression trial PharmaTimes

Beckley Psytech Announces Partnership With Empatica in Latest Step of Digital Strategy, Designed to Deliver Personalised Patient Care - Business Wire

Beckley Psytech Announces Partnership With Empatica in Latest Step of Digital Strategy, Designed to Deliver Personalised Patient Care Business Wire

IV Psilocin Benzoate for Major Depressive Disorder: New Phase 2a Results - Psychiatric Times

IV Psilocin Benzoate for Major Depressive Disorder: New Phase 2a Results Psychiatric Times

Beckley Psytech Strengthens Senior Leadership Team With Appointment of Dr. Laura Trespidi as Chief Development Officer - Business Wire

Beckley Psytech Strengthens Senior Leadership Team With Appointment of Dr. Laura Trespidi as Chief Development Officer Business Wire

First Participant Dosed in Study of BPL-003 Neurophysiological Effects - Psychiatric Times

First Participant Dosed in Study of BPL-003 Neurophysiological Effects Psychiatric Times

Beckley Psytech acquires Eleusis Therapeutics - Labiotech.eu

Beckley Psytech acquires Eleusis Therapeutics Labiotech.eu

atai Life Sciences Makes $50m Investment in Beckley Psytech - Psychedelic Alpha

atai Life Sciences Makes $50m Investment in Beckley Psytech Psychedelic Alpha

Negev Labs Emerges from Stealth with Announcement of Alexander Shulgin Research Institute Licensing Agreement, Acquisition of Beckley Psytech Development Program and R&D Collaboration with Hadassah Brain Labs Center for Psychedelic Research - PR Newswire

Negev Labs Emerges from Stealth with Announcement of Alexander Shulgin Research Institute Licensing Agreement, Acquisition of Beckley Psytech Development Program and R&D Collaboration with Hadassah Brain Labs Center for Psychedelic Research PR Newswire

Beckley Psytech bags $80M to fuel psychedelics for depression, debilitating headaches - Fierce Biotech

Beckley Psytech bags $80M to fuel psychedelics for depression, debilitating headaches Fierce Biotech

Oxford scale-ups want to upgrade the world - WIRED

Oxford scale-ups want to upgrade the world WIRED

Beckley Psytech Raises £14m ($18.6m) to Advance Development of 5-MeO-DMT for Neuropsychiatric Diseases - Psychedelic Alpha

Beckley Psytech Raises £14m ($18.6m) to Advance Development of 5-MeO-DMT for Neuropsychiatric Diseases Psychedelic Alpha

Could 5-MeO-DMT Allow For More Affordable Psychedelic-Assisted Therapy? Beckley Psytech Thinks So - Forbes

Could 5-MeO-DMT Allow For More Affordable Psychedelic-Assisted Therapy? Beckley Psytech Thinks So Forbes

Are psychedelic drugs headed for the mainstream? - Sifted

Are psychedelic drugs headed for the mainstream? Sifted

Companies like Beckley Psytech

Delix Therapeutics logo - Similar company to Beckley Psytech

Delix Therapeutics

29
Clerkenwell Health logo - Similar company to Beckley Psytech

Clerkenwell Health

53
Cybin Inc logo - Similar company to Beckley Psytech

Cybin Inc

80
Lykos Therapeutics logo - Similar company to Beckley Psytech

Lykos Therapeutics

90
atai Life Sciences logo - Similar company to Beckley Psytech

Atai Life Sciences

76
Mindbloom logo - Similar company to Beckley Psytech

Mindbloom

169
MindMed logo - Similar company to Beckley Psytech

Mindmed

115
Multidisciplinary Association for Psychedelic Studies (MAPS) logo - Similar company to Beckley Psytech

Multidisciplinary As...

111
Solvonis Therapeutics (formerly Awakn) logo - Similar company to Beckley Psytech

Solvonis Therapeutic...

5
Compass Pathways logo - Similar company to Beckley Psytech

Compass Pathways

219

Top Beckley Psytech Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant